1. Scott, DL, Wolfe, F, Huizinga, TW. Rheum arthritis. Lancet 2010; 376: 1094–1108.
Google Scholar | Crossref | Medline | ISI2. Cook, MJ, Diffin, J, Scire, CA, et al. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology 2016; 55: 1601–1609.
Google Scholar | Crossref | Medline3. Ma, MHY, Ibrahim, F, Kingsley, GH, et al. Variable impacts of different remission states on health-related quality of life in rheumatoid arthritis. Clin Exp Rheumatol 2018; 36: 203–209.
Google Scholar | Medline4. Wolfe, F, Rasker, JJ, Boers, M, et al. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Arthritis Care Res 2007; 57: 935–942.
Google Scholar | Crossref5. Siemons, L, Ten Klooster, PM, Vonkeman, HE, et al. Distinct trajectories of disease activity over the first year in early rheumatoid arthritis patients following a treat-to-target strategy. Arthritis Care Res 2014; 66: 625–630.
Google Scholar | Crossref6. Norton, S, Fu, B, Scott, DL, et al. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum 2014; 44: 131–144.
Google Scholar | Crossref | Medline7. Bukhari, M, Thomson, W, Naseem, H, et al. The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 2007; 56: 2929–2935.
Google Scholar | Crossref | Medline8. van Gaalen, FA, van Aken, J, Huizinga, TW, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113–2121.
Google Scholar | Crossref | Medline9. Cope, AP, Barnes, MR, Belson, A, et al. The RA-MAP Consortium: a working model for academia-industry collaboration. Nat Rev Rheumatol 2018; 14: 53–60.
Google Scholar | Crossref | Medline10. Aletaha, D, Neogi, T, Silman, AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569–2581.
Google Scholar | Crossref | Medline11. Arnett, FC, Edworthy, SM, Bloch, DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.
Google Scholar | Crossref | Medline12. NICE . The management of rheumatoid arthritis in adults (Clinical guideline 79). London: NICE, 2009, www.nice.org.uk/CG79
Google Scholar13. Aletaha, D, Smolen, J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23(5 Suppl. 39): S100–S108.
Google Scholar | Medline14. Anderson, J, Caplan, L, Yazdany, J, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res 2012; 64: 640–647.
Google Scholar | Crossref | Medline15. Anderson, JK, Zimmerman, L, Caplan, L, et al. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res 2011; 63(Suppl. 11): S14–S36.
Google Scholar | Medline16. Dougados, M, Aletaha, D, van Riel, P. Disease activity measures for rheumatoid arthritis. Clin Exp Rheumatol 2007; 25: S22–S29.
Google Scholar | Medline17. Felson, DT, Smolen, JS, Wells, G, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011; 63: 573–586.
Google Scholar | Crossref | Medline18. Larsen, A . A radiological method for grading the severity of rheumatoid arthritis. Scand J Rheumatol 1975; 4: 225–233.
Google Scholar | Crossref | Medline19. Larsen, A, Dale, K, Eek, M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977; 18: 481–491.
Google Scholar | SAGE Journals20. Scott, DL, Houssien, DA, Laasonen, L. Proposed modification to Larsen’s scoring methods for hand and wrist radiographs. Br J Rheumatol 1995; 34: 56.
Google Scholar | Crossref | Medline21. Fries, JF, Spitz, P, Kraines, RG, et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–145.
Google Scholar | Crossref | Medline22. Hurst, NP, Kind, P, Ruta, D, et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551–559.
Google Scholar | Crossref | Medline23. Linde, L, Sørensen, J, Østergaard, M, et al. Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008; 35: 1528–1537.
Google Scholar | Medline | ISI24. Ruta, DA, Hurst, NP, Kind, P, et al. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol 1998; 37: 425–436.
Google Scholar | Crossref | Medline25. Forslind, K, Hafström, I, Ahlmen, M, et al. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007; 66: 46–52.
Google Scholar | Crossref | Medline | ISI26. Katchamart, W, Johnson, S, Lin, HJ, et al. Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res 2010; 62: 1128–1143.
Google Scholar | Crossref | Medline27. Furst, DE, Pangan, AL, Harrold, LR, et al. Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry. Arthritis Care Res 2011; 63: 856–864.
Google Scholar | Crossref | Medline28. Castrejón, I, Dougados, M, Combe, B, et al. Prediction of remission in a French early arthritis cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein antibodies, or radiographic erosions. J Rheumatol 2016; 43: 1285–1291.
Google Scholar | Crossref | Medline29. RA-MAP Consortium . Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD Open 2018; 4: e000721.
Google Scholar | Crossref | Medline30. Baganz, L, Richter, A, Albrecht, K, et al. Are prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohorts. Semin Arthritis Rheum 2019; 48: 976–982.
Google Scholar | Crossref | Medline31. R Core Team . R: a language and environment for statistical computing (Computer software). Vienna: R Foundation for Statistical Computing, 2017.
Google Scholar32. Vandenbroucke, JP, Von Elm, E, Altman, DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4: e297.
Google Scholar | Crossref | Medline | ISI33. Charlson, ME, Pompei, P, Ales, KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
Google Scholar | Crossref | Medline34. Charlson, ME, Charlson, RE, Peterson, JC, et al. The Charlson Comorbidity Index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008; 61: 1234–1240.
Google Scholar | Crossref | Medline | ISI35. Aletaha, D, Funovits, J, Keystone, EC, et al. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 2007; 56: 3226–3235.
Google Scholar | Crossref | Medline36. Dunlop, DD, Semanik, P, Song, J, et al. Risk factors for functional decline in older adults with arthritis. Arthritis Rheum 2005; 52: 1274–1282.
Google Scholar | Crossref | Medline37. Kim, S-K, Park, S-H, Shin, I-H, et al. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol 2008; 35: 995–1001.
Google Scholar | Medline | ISI38. Maxwell, JR, Gowers, IR, Moore, DJ, et al. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology 2010; 49: 2140–2146.
Google Scholar | Crossref | Medline | ISI39. Nissen, MJ, Gabay, C, Scherer, A, et al. The effect of alcohol on radiographic progression in rheumatoid arthritis. Arthritis Rheum 2010; 62: 1265–1272.
Google Scholar | Crossref | Medline40. Papadopoulos, NG, Alamanos, Y, Voulgari, PV, et al. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005; 23: 861–866.
Google Scholar | Medline41. Covas, MI, Gambert, P, Fitó, M, et al. Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis 2010; 208: 297–304.
Google Scholar | Crossref | Medline42. Lu, B, Solomon, DH, Costenbader, KH, et al. Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis. Arthritis Rheum 2010; 62: 3554–3559.
Google Scholar | Crossref | Medline43. Kronisch, C, McLernon, DJ, Dale, J, et al. Brief report: predicting functional disability: one-year results from the Scottish Early Rheumatoid Arthritis inception cohort. Arthritis Rheumatol 2016; 68: 1596–1602.
Google Scholar | Crossref | Medline44. Barnabe, C, Sun, Y, Boire, G, et al. Heterogeneous disease trajectories explain variable radiographic, function and quality of life outcomes in the Canadian Early Arthritis Cohort (CATCH). PLoS ONE 2015; 10: e0135327.
Google Scholar | Crossref | Medline45. Wabe, N, Sorich, MJ, Wechalekar, MD, et al. Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years. Arthritis Res Ther 2015; 17: 48.
Google Scholar | Crossref | Medline